Stephen DeWall

Stephen D. has a strong background in the biotechnology industry, with over 20 years of work experience. Stephen is currently serving as the Head of Bioanalytical Sciences at Scholar Rock since 2022. Prior to this, they held the position of Senior Director - Biomarkers and Precision Medicine at Passage Bio from April 2021 to January 2022. From August 2020 to April 2021, they worked as the Immunogenicity Leader at Spark Therapeutics, Inc.

Stephen's work experience also includes a significant tenure at GlaxoSmithKline, where they held multiple roles. Stephen served as the Group Leader - Immunogenicity and Clinical Immunology from November 2015 to August 2020, and as a Principal Scientist / Investigator from September 2010 to November 2015. Before their time at GlaxoSmithKline, Stephen worked at Siemens Healthcare as a Senior Manager, R&D from May 2005 to September 2010.

Stephen began their career as a Postdoctoral Fellow at Harvard Medical School from March 2000 to April 2005. Stephen'sdiverse work experience and expertise in bioanalytical sciences and immunogenicity make him a valuable asset in the biotechnology industry.

Stephen D. obtained a PhD in Biology and Biomedical Sciences from Washington University School of Medicine in St. Louis. No information is provided regarding the start and end years of this education.